Yuling Li
Co-founder and CEO (2018 08-2023 07), President (2023 08 - Present) at Innoforce Pharmaceuticals
Based in United States
7-day free trial · no credit card
Seniority
Other
Department
Other
Location
United States
Industry
Pharmaceutical Manufacturing
Company size
28
Contact information
Reveal Yuling's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
y•••••••@innoforcepharma.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Yuling Li
High performing scientific and organizational leader in biopharmaceutical development from clinical to commercialization • Building innovation enabling capabilities to connect the East and the West pharmaceutical development • Proven expertise in broad aspects of biopharmaceutical CMC functions • Strong technical and operational leadership in both strategic and tactical functions with proficient planning and effective execution • Effective cross-functional project and team leader and consensus builder • Dedicated and effective mentor to next generation of scientists Specialties: Biopharmaceutical Development, Technology Transfer, CMC, cGMP, Regulatory Compliance, International Collaborations and Partnership, China/Asia Development Strategies
Decision-makers
Other people at Innoforce Pharmaceuticals
- RYManager
Rong Yi
Senior Technical Account Manager · Information Technology
- HRManager
Hongxun Ruan
Validation Supervisor · Manufacturing & Production
- WCStaff
Wanfen Chen
Business Development · Sales & Business Development
- WCStaff
Wencong Cui
Senior Sciencitist · Other
- CXManager
Chang Xu
Equipment Supervisor · Manufacturing & Production
Build a list of verified contacts at Innoforce Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Yuling
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime